Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies
Michał Ciebiera(Medical University of Warsaw), Ayman Al‐Hendy(Khalifa University of Science and Technology), Samar Alkhrait(University of Chicago), Ana Corachán(Universitat de València), Grzegorz Jakiel(Postgraduate School of Molecular Medicine), Jakub Kociuba(Postgraduate School of Molecular Medicine), Iana Malasevskaia(Yemenia University), Obianuju Sandra Madueke-Laveaux(University of Chicago), Robert Spaczyński(University of Zielona Góra), Qiwei Yang(University of Illinois Chicago), Natalia Żeber‐Lubecka(Postgraduate School of Molecular Medicine), Tomasz Łoziński, Marta Włodarczyk(Medical University of Warsaw), Monika Bączkowska(Postgraduate School of Molecular Medicine), Elżbieta Zarychta(Postgraduate School of Molecular Medicine), Somayeh Vafaei(Iran University of Medical Sciences), Piotr Laudański(Medical University of Warsaw), Mohamed Ali(Ain Shams University)
Cited by 13
Related Papers
Obesity, DNA Damage, and Development of Obesity-Related Diseases
|International Journal of Molecular Sciences|2019|231
New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese
|Kardiologia Polska|2017|176
Role of Transforming Growth Factor β in Uterine Fibroid Biology
|International Journal of Molecular Sciences|2017|107
Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids
|Fertility and Sterility|2016|89
Vitamin D and Uterine Fibroids—Review of the Literature and Novel Concepts
|International Journal of Molecular Sciences|2018|81